Brooks Life Sciences site in Germany approved to store and ship all categories of clinical trials supplies and human pharmaceutical products

Clinical trials supplies and pharma products

INDIANAPOLIS, Ind. – January 2020 – Brooks Life Sciences announced that their biorepository in Griesheim, Germany has received approval to store and transport clinical trials supplies and pharma products.

The Regierungspräsidium Darmstadt, Department of Drug Safety (German FDA equivalent) has inspected the Griesheim biorepository and approved Brooks to store and ship all categories of human pharmaceutical product.

Product categories include active pharmaceutical ingredients (APIs), investigational medicinal products (IMPs), clinical trial samples, finished medicinal pharmaceuticals, and intermediate synthesis compounds

Vice President of Services and Informatics for Brooks Life Sciences, Martin Long, summarizes the value of this approval.

“Brooks Life Sciences is world renowned for expertise in storing patient samples collected during clinical trials and is now able to store the corresponding clinical supplies and finished drug product,” he stated. 

“As trial sponsors look to consolidate vendors to reduce costs, trial times, and improve patient outcomes,” Long continued, “we are committed to providing a quality, highly responsive logistics, and storage service for clinical trial samples. Now, we can provide this same level of service for clinical supplies and approved drug product.”

Long went on to say, “We’re particularly excited about how this enables us to support the emerging cell and gene therapy space with a robust logistics and storage service for pre-clinical and clinical research and approved manufactured product.”

As a leader in Europe, Brooks Life Sciences sets a standard in sample management to support clients at every level in accelerating quality research and outcomes.

About Brooks Life Sciences
Brooks Life Sciences, a division of Brooks Automation, provides the life sciences industry with the most comprehensive portfolio of sample management solutions, enabling researchers worldwide to accelerate innovation and improve patient health. The company provides automated storage, cryopreservation, informatics, sample and GMO storage, and gene sequencing and synthesis through their company, GENEWIZ. Brooks also offers lab services, transportation, consumables, and instruments. Technologies and services span the entire cold chain supporting research, GMP, pre/clinical, cell therapy, and biologics. The top 20 biopharmaceutical providers and other leading companies rely on Brooks Life Sciences to advance research.